News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

|Articles|December 15, 2019

BioPharm International

BioPharm International-12-15-2019
Volume 2019 eBook
Issue 5

Resources, Guidelines, and Guidance Documents

Find links to pertinent regulatory and standard setting resources, guidance documents, and guidelines.

Find links to pertinent regulatory and standard setting resources, guidance documents, and guidelines.

Read this article in BioPharm International’s December 2019 Regulatory Sourcebook.

Articles in this issue

over 6 years ago

Article

Revision Process for Global/National Pharmacopoeias (eBook)

over 6 years ago

Article

Surveillance Process for Industry: Monitoring Pharmacopoeia Revisions (eBook)

over 6 years ago

Article

Warning Letters Signal Steps to Compliance

over 6 years ago

Article

Lessons from FDA 483s and cGMP Inspection Data

over 6 years ago

Article

Regulatory and Standard Setting Organizations

over 6 years ago

Article

Quality Risk Management Plans Create Effective Quality Systems

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

Bispecific antibody colored heavy chain in green and pink, light chain blue and yellow against gray background; glycosylated bispecific immunoglobulin engineered to target different antigens 3d render | Image credit: © huenstructurebio.com - © huenstructurebio.com - stock.adobe.com

Talquetamab Plus Daratumumab Combination Reduces Progression Risk by Up to 72% in Phase 3 Relapsed Multiple Myeloma Trial

ByFeliza Mirasol

June 15th 2026

Human Respiratory System Lungs Anatomy | Image credit: © magicmine - © magicmine - stock.adobe.com

FDA Expands Tocilizumab Biosimilar's Label to CRS and Pediatric COVID-19

ByFeliza Mirasol

June 11th 2026

a young girl with atopic dermatitis in the acute stage. redness and scratching up to blood on the body close-up. Dermatology | Image credit: © Ksenia Kirillovykh - © Ksenia Kirillovykh - stock.adobe.com

FDA Approves Lebrikizumab Every-8-Week Maintenance Dosing for Moderate-to-Severe Atopic Dermatitis

ByFeliza Mirasol

June 10th 2026

Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image credit: © LASZLO - © LASZLO - stock.adobe.com

EC Approves Sanofi’s Subcutaneous Isatuximab for Multiple Myeloma Across All Existing Indications

ByFeliza Mirasol

June 8th 2026

A Q&A with Dr. Ganesh Bala on LC–MS and Multi-Attribute Methods for Bioconjugate CQA Monitoring

ByFeliza Mirasol,Ganesh Bala

June 4th 2026